|
|
|
|
| LEADER |
00000cam a2200000 7i4500 |
| 001 |
0000080359 |
| 005 |
20130107.0 |
| 008 |
110523s2013 mau eng |
| 020 |
|
|
|a 9780763770990 (pbk. : alk. paper)
|
| 050 |
0 |
0 |
|a RS100
|b .U53 2013
|
| 060 |
1 |
0 |
|a QV 736
|b U55 2013
|
| 090 |
0 |
0 |
|a QV 736
|b U55 2013
|
| 245 |
1 |
0 |
|a Understanding health outcomes and pharmacoeconomics
|c [edited by] George E MacKinnon III
|
| 260 |
|
|
|a Burlington, MA :
|b Jones & Bartlett Learning ,
|c c2013
|
| 300 |
|
|
|a xxii, 218 p. :
|b ill. ;
|c 23 cm.
|
| 504 |
|
|
|a Includes bibliographical references and index
|
| 505 |
0 |
|
|a 1. Drug approval process -- 2. Measuring health status and health-related quality of life assessment -- 3. Health surveys (disease specific and generic questionnaires) and utility assessment -- 4. Overview of statistical analyses in biomedical research -- 6. Randomized clinical trials -- 7. Systematic reviews and meta analyses -- 8. Medical and prescription claims databases -- 9. Uses of patient registries in evidence development -- 10. Decision analysis -- 11. Introduction to economic analysis, cost determinants and modeling -- 12. Cost-of-illness analysis and budget impact models -- 13. Cost-benefit analysis, cost-effectiveness analysis and cost-utility analysis -- 14. Comparative effectiveness
|
| 650 |
|
0 |
|a Drug development
|x Economic aspects
|
| 650 |
|
0 |
|a Drugs
|x Cost effectiveness
|
| 650 |
|
0 |
|a Outcome Assessment (Health Care)
|
| 650 |
|
0 |
|a Pharmaceutical industry
|x Economic aspects
|
| 650 |
|
2 |
|a Economics, Pharmaceutical
|
| 650 |
2 |
2 |
|a Costs and Cost Analysis
|x methods
|
| 650 |
2 |
2 |
|a Outcome Assessment (Health Care)
|x economics
|
| 700 |
1 |
|
|a MacKinnon, George E. ,
|e author
|
| 999 |
|
|
|a 1000149756
|b Book
|c OPEN SHELF (30 DAYS)
|e Medical Campus
|